SANDRA ROCHA: Open Payments
NPI 1730717216 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,292 in 98 payments from 22 companies in 2025. Trend: 2023 $1,681 · 2024 $2,630 · 2025 $2,292
Food & beverage: $2,292
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 22 | $496 |
| AstraZeneca Pharmaceuticals LP | 6 | $322 |
| Lilly USA, LLC | 11 | $312 |
| Sumitomo Pharma America, Inc. | 4 | $167 |
| Dexcom, Inc. | 8 | $153 |
| PFIZER INC. | 8 | $151 |
| ABBVIE INC. | 9 | $149 |
| Exact Sciences Corporation | 4 | $80 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $68 |
| Inspire Medical Systems, Inc. | 3 | $56 |
Products named: Ozempic, AIRSUPRA, MOUNJARO, GEMTESA, Dexcom G6 Transmitter, Wegovy, NURTEC ODT, QULIPTA.
Industry payments across TX — which companies pay providers there.
